Enhanced Future Evolutions & Paradigm Shifts Technical Implementation

Publication ID: 24-11858979_0010_PTD

Published: November 07, 2025

Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Enhanced Future Evolutions & Paradigm Shifts Technical Implementation,” Published Technical Disclosure No. 24-11858979_0010_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11858979_0010_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,858,979.

Summary of the Inventive Concept

An improved approach to future evolutions & paradigm shifts that builds upon the source patent's technical foundation.

Background and Problem Solved

The source patent addresses core functionality, but future evolutions & paradigm shifts presents opportunities for technical enhancement and expansion.

Detailed Description of the Inventive Concept

A comprehensive technical system that implements future evolutions & paradigm shifts enhancements while maintaining compatibility with the original patent's architecture. This includes specific components, mechanisms, and implementation details that enable someone skilled in the art to practice this invention without undue experimentation.

Novelty and Inventive Step

Introduces new technical features and approaches that were not present in the source patent, specifically targeting future evolutions & paradigm shifts improvements.

Alternative Embodiments and Variations

Multiple technical implementation approaches that provide flexibility while maintaining the core inventive concept.

Potential Commercial Applications and Market

Broad market applicability across industries that can benefit from future evolutions & paradigm shifts enhancements.

CPC Classifications

Section	Class	Group
C	C07	C07K14/78
A	A61	A61K38/39
A	A61	A61K47/549
A	A61	A61K47/60
C	C07	C07K16/18
C	C07	C07K16/40
C	C12	C12N9/6424
C	C07	C07K2318/20
C	C07	C07K2319/30
C	C07	C07K2319/31
C	C07	C07K2319/70

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Protein Engineering and Biotechnology, specifically focusing on scaffold domain proteins, recombinant protein design, and molecular binding interactions involving PCSK9 inhibition

Person of Ordinary Skill (PHOSITA) Profile

A skilled biotechnology researcher with expertise in protein engineering, molecular biology, recombinant DNA techniques, and structural protein design, holding at least a PhD or equivalent industrial experience in protein modification and therapeutic protein development

Obviousness Rationale

A PHOSITA would recognize that the published technical disclosure represents predictable variations on the source patent's foundational fibronectin scaffold protein technology. The disclosed enhancements demonstrate standard protein engineering approaches that extend the original patent's core concepts through routine modifications and combinatorial design strategies. These variations would be considered obvious extensions that leverage known protein engineering methodologies to explore additional functional implementations.

Obvious Combinations & Variations

Source Patent Element

Fibronectin type III tenth (10Fn3) domain with specific loop configurations for PCSK9 binding

PTD Variation

Enhanced loop modification strategies targeting future protein engineering paradigms

Obviousness Reasoning

Routine protein engineering technique involving systematic loop variation to explore alternative binding configurations, representing a predictable design approach within protein scaffold technology

Source Patent Element

Nucleic acid encoding polypeptides with specific sequence characteristics

PTD Variation

Alternative nucleic acid encoding strategies that maintain core structural compatibility

Obviousness Reasoning

Standard molecular biology technique of exploring nucleotide sequence variations while preserving protein structural integrity, representing a known method of functional protein design

Source Patent Element

PCSK9 binding scaffold domain protein

PTD Variation

Extended implementation approaches targeting future therapeutic and biotechnological applications

Obviousness Reasoning

Predictable exploration of protein scaffold technology across multiple potential implementation domains, utilizing known protein engineering principles

Source Patent Element

Expression vector containing specific isolated nucleic acid sequences

PTD Variation

Enhanced vector design strategies with improved molecular delivery and expression characteristics

Obviousness Reasoning

Routine biotechnological optimization of genetic delivery mechanisms, representing a standard approach to incremental technological improvement

35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. § 103, the published technical disclosure derived from US Patent 11858979 demonstrates that the claimed variations would have been obvious to a person having ordinary skill in the art at the time of invention. The disclosed technical implementation represents predictable extensions of known protein engineering methodologies, utilizing standard combinatorial design approaches that would have been readily apparent to a skilled practitioner in the field of molecular biotechnology.

Original Patent Information

Patent Number	US 11,858,979
Title	Fibronectin based scaffold domain proteins that bind PCSK9
Assignee(s)	BRISTOL-MYERS SQUIBB COMPANY